ImmuneID

About:

ImmuneID is a precision immunology company.

Top Investors: Alexandria Venture Investments, Section 32, Xfund, In-Q-Tel, Alta Partners

Description:

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.

Total Funding Amount:

$67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)immuneidrx.com

Founders:

Christoph Westphal, Lea Hachigian

Number of Employees:

11-50

Last Funding Date:

2021-06-23

IPO Status:

Private

Industries: